Young cancer survivors at higher risk of becoming unemployed and economically dependent, study shows

NewsGuard 100/100 Score

If you survive cancer at young age, then you have a higher risk of becoming unemployed and economically dependent than others, a Norwegian study shows.

Children, adolescents and young adults that have survived cancer have a higher risk of becoming unemployed and needing governmental financial assistance. This is the result of a study carried out at the Department of Global Public Health and Primary Care, at the University of Bergen.

"The aim of the study was see how young cancer survivors are doing economically in adult life. I discovered a considerable risk of unemployment in this group," says researcher Maria Winther Gunnes, who has recently published the study in the scientific journal Cancer

The study shows that young cancer survivors:

* have a 40 per cent higher risk of becoming unemployed, than others.
* have a 40 per cent higher risk of receiving governmental financial assistance
* and that female survivors are more vulnerable than men regarding economic independency.

No follow up for young adults

Gunnes has mapped how many of the Norwegians born between 1965 and 1985 got a cancer diagnosis before the age of 25. She then studied how these performed economically and in working life , compared to the others who did not receive a cancer diagnosis. She collected data in large Norwegian national registers like NAV, Statistics Norway (SSB),and The Norwegian Tax Administration and The Cancer Registry of Norway.

"As a paediatric oncologist, I am interested in how the young survivors are doing," says Gunnes.

"Maybe one thinks that if somebody survives cancer, they will do well later. Even if that is the case for many, we also see that quite many struggle and are getting too littlehelp."

Rough treatment

Gunnes believes that the reason behind the experience of struggle, is because of rough cancer treatment including radiation and chemotherapy, which may can be devastating  for young bodies and brains under development. For young adults, the reason may be that they need a long break from education and work, just when they have started. It can be hard to catch up with your peers after such a break.

"We need more follow-up in terms of  career planning and work rehabilitation programs to help the survivors enter the job market. In the study, we saw that the cancer survivors, when holding a job, didn't perform much worse than other workers," says Gunnes.

Childhood cancer survivors in Norway at the moment receive medical follow-up  for  approximately ten years after the end of treatment. When the patients are around 18 years old, there is no organized follow-up. They visit their GPs, who naturally have limited experience in the follow-up of such patients due to the rarity of childhood cancer, and the national health service has no knowledge of what happens to them.

"Other countries like the Nederlands, Portugal and USA have late-effect follow-up clinics, where the survivors can visit and meet a competent interdisciplinary team. In Norway, the survivors disappear to GPs who naturally have very little experience with this type of patients," says Maria Winther Gunnes.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New trials show promise for immune checkpoint blockers in early-stage lung cancer